Nodality scores $3.5M for personal diagnostics
Nodality, a biotech company that makes diagnostics focused on cell pathways, has brought in $3.5 million of an expected $10 million round of equity, according to a filing with the SEC. Based in South San Francisco, its backers include Kleiner Perkins Caufield & Byers, Maverick Capital and TPG Biotechnology.
Next Story: JukeFly re-launches personal online music player
Previous Story: Augmented reality company Layar gets $1M boost, launches on Symbian
About the Author, Camille Ricketts
Camille is the lead writer for GreenBeat. She came to VentureBeat from Google where she worked on its traditional platforms team, particularly in TV. Before that, she was a reporter for the Wall Street Journal in New York and London. Follow her on Twitter at @camillericketts, and follow VentureBeat on Twitter at @venturebeat.
With GreenBeat 2009, VentureBeat's all-star conference on all things Smart Grid, coming up in November, Camille will be expanding coverage of this exciting space. Stay up to date by following @greenbeat2009 on Twitter or by becoming a fan of the event on Facebook here.